ING Groep NV acquired a new stake in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) during the second quarter, Holdings Channel reports. The fund acquired 22,075 shares of the software maker’s stock, valued at approximately $282,000.

Several other institutional investors have also bought and sold shares of MDRX. FNY Partners Fund LP boosted its position in Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock valued at $101,000 after buying an additional 7,200 shares in the last quarter. Invictus RG acquired a new position in Allscripts Healthcare Solutions during the first quarter valued at $105,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Allscripts Healthcare Solutions by 9.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock valued at $120,000 after buying an additional 816 shares in the last quarter. Bank of Montreal Can boosted its position in Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after buying an additional 3,724 shares in the last quarter. Finally, Flinton Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 4.1% in the first quarter. Flinton Capital Management LLC now owns 9,940 shares of the software maker’s stock valued at $126,000 after buying an additional 392 shares in the last quarter.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded up 1.38% during midday trading on Friday, hitting $12.52. The stock had a trading volume of 740,109 shares. The company’s market cap is $2.26 billion. The company’s 50 day moving average is $12.50 and its 200 day moving average is $12.15. Allscripts Healthcare Solutions, Inc. has a 1-year low of $9.80 and a 1-year high of $13.70.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The company had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. During the same quarter last year, the business earned $0.14 earnings per share. The company’s revenue was up 10.2% on a year-over-year basis. On average, equities analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/ing-groep-nv-invests-282000-in-allscripts-healthcare-solutions-inc-mdrx/1472888.html.

Several research firms recently weighed in on MDRX. Bank of America Corporation began coverage on Allscripts Healthcare Solutions in a research report on Monday, May 15th. They set a “neutral” rating and a $14.00 price objective for the company. Leerink Swann cut Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $15.00 to $13.00 in a research report on Monday, June 19th. Cantor Fitzgerald reissued a “neutral” rating and set a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. BidaskClub raised Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, Maxim Group reissued a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, May 5th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $14.66.

In other news, President Richard J. Poulton sold 25,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the sale, the president now directly owns 412,488 shares in the company, valued at $4,974,605.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.75% of the stock is currently owned by insiders.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.